Nerve Growth Factor (Ngf) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Nerve Growth Factor (Ngf) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Nerve Growth Factor (NGF) is the prototypical member of the neurotrophin family of growth factors, playing a fundamental role in the development, maintenance, and plasticity of specific neuronal populations in both the central and peripheral nervous systems. As the first growth factor ever discovered, NGF has served as a paradigm for understanding neurotrophic factor biology and remains a major focus of research in neurodegenerative diseases and neural repair.[@levimontalcini1987]
Structure
NGF is synthesized as a pre-propeptide that undergoes proteolytic processing:
Precursor: Pre-pro-NGF contains a signal peptide and propeptide domain
Pro-NGF: The 27 kDa precursor can be secreted and has distinct biological activities
Mature NGF: The 12 kDa beta-NGF homodimer is the biologically active form
The three-dimensional structure reveals a homodimer with each monomer containing a cysteine knot motif, a characteristic of the neurotrophin family.[@wiesmann1996]
Function
Development
During development, NGF is essential for:
Neuronal survival: Retrograde support of specific populations
Axonal targeting: Chemotropic guidance of growing axons
Synaptogenesis: Formation of appropriate synaptic connections
Cell differentiation: Specification of neuronal phenotype
Adult Brain
In the adult nervous system, NGF continues to modulate:
Basal forebrain cholinergic function: Maintenance of cortical-projecting BFCNs
Synaptic plasticity: Modulation of [LTP](/mechanisms/long-term-potentiation) and memory processes
Neuroprotection: Trophic support against injury and disease
Receptor Interactions
TrkA (NTRK1)
The high-affinity TrkA receptor mediates the classic neurotrophic effects of NGF:[@chao2003]
Dimerization and autophosphorylation upon NGF binding
Downstream signaling cascades:
PI3K/Akt → survival
Ras/MEK/ERK → differentiation
PLC-gamma → plasticity
p75NTR
The p75 neurotrophin receptor modulates NGF responses:[@hempstead2002]
Enhances TrkA signaling when co-expressed
Mediates [apoptosis](/entities/apoptosis) when acting alone or with pro-NGF
Regulates synaptic plasticity through various signaling pathways
Clinical Applications
Alzheimer's Disease
NGF therapy has been investigated for AD due to:[@chao2003]
Cholinergic neuron degeneration in basal forebrain
Evidence of impaired NGF signaling in AD
Potential to support remaining BFCNs
Clinical approaches have included:
Gene therapy: AAV-mediated NGF delivery to the basal forebrain
The study of Nerve Growth Factor (Ngf) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
References
[Levi-Montalcini R, The nerve growth factor: thirty-five years later (1987)](https://doi.org/10.1126/science.2880399)
[Wiesmann C, Ultsch MH, Bass SH, de Vos AM, Crystal structure of nerve growth factor at 2.6 Å resolution (1996)](https://doi.org/10.1016/S0969-2126(96)
[Chao MV, Neurotrophins and their receptors: a convergence point for many signalling pathways (2003)](https://doi.org/10.1038/nrn1078)
[Hempstead BL, The many faces of p75NTR (2002)](https://doi.org/10.1016/S0959-4388(02)
[Longo FM, Massucci S, Zaccaria ML, et al, Small molecule NGF mimetics: a novel therapeutic approach for Alzheimer's disease (2007)](https://doi.org/10.1007/s12031-007-0081-3)
[Tuszynski MH, Thal L, UHS M, et al, Nerve growth factor gene therapy for Alzheimer's disease (2005)](https://doi.org/10.1038/nm1239)
[Cattaneo A, Calissano P, Nerve growth factor and Alzheimer's disease: new facts for an old hypothesis (2012)](https://doi.org/10.1007/s12035-012-8288-3)
[Allen SJ, Watson JJ, Shoemark KD, Williams NH, Patel DK, GDNF, NGF and BDNF as therapeutic options for neurodegeneration (2013)](https://doi.org/10.1016/j.pharmthera.2013.01.004)
[Sebollela A, CTemporaryTarget V, Sathler LB, et al, Amyloid-beta oligomers induce differential gene expression in human neural cells (2019)](https://doi.org/10.1007/s12035-018-1421-1)
[Mufson EJ, Counts SE, Perez SE, Binder LI, Cholinergic system during the progression of Alzheimer's disease: therapeutic implications (2008)](https://doi.org/10.3233/JAD-2008-15102)
[Schliebs R, Arendt T, The cholinergic system in aging and neuronal degeneration (2011)](https://doi.org/10.1016/j.bbr.2010.11.058)
[Eriksdotter Jönhagen M, Nordberg A, Amberla K, et al, Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease (1998)](https://doi.org/10.1159/000017059)
[Williams BJ, Eriksdotter-Jönhagen M, Granholm AC, Nerve growth factor in treatment and pathogenesis of Alzheimer's disease (2006)](https://doi.org/10.1016/j.pnpbp.2006.01.023)
[About-Samar R, Sidhu PS, Dixon K, Nerve growth factor and Alzheimer's disease: new facts for an old hypothesis (2020)](https://doi.org/10.4103/1673-5374.284009)
[Ibáñez CF, Simi A, p75 neurotrophin receptor signaling in nervous system injury and degeneration: paradoxes and potentials (2012)](https://doi.org/10.1016/j.expneurol.2011.12.032)